Evidence map›Paper›PMID 37255586›Full record

ArticleSocio-economic planning sciences2023

Strategic planning for the optimal distribution of COVID-19 vaccines.

Rogelio Ochoa-Barragán, Aurora Del Carmen Munguía-López, José María Ponce-Ortega

Abstract read
In one paragraph

Article in Socio-economic planning sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rogelio Ochoa-BarragánDepartment of Chemical Engineering, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, 58060, México.
Aurora Del Carmen Munguía-LópezDepartment of Chemical Engineering, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, 58060, México.
José María Ponce-OrtegaDepartment of Chemical Engineering, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán, 58060, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work presents a multi-objective optimization strategy for fair vaccine allocation through different fairness schemes. The proposed approach considers a diverse series of parameters related to different public health data and social behaviors that influence the correct distribution of vaccines, such as corruption and crime. Simultaneously, the formulation includes prioritizing those groups with the highest risk based on the epidemiological traffic light. Furthermore, the presented strategy involves different budget constraints that allow identifying trade-off solutions through Pareto fronts. Therefore, vaccine allocations are obtained by combining fairness concepts with multi-objective optimization. The applicability of the model is illustrated using the case study of Mexico. The solution to the proposed scenarios was carried out using different justice schemes and an economic objective function. The results show the compromises between a satisfaction index and costs, which are shown through Pareto optimal solutions that allow selecting the solutions that balance the objectives. The solutions provided by the social welfare scheme suggest a greater allocation of vaccines to those states with higher epidemiological risk, which may be helpful in the first stage of vaccination. On the other hand, the Rawlsian scheme provides more balanced solutions that can be useful in situations with lower rates of infection. Finally, the Nash scheme is the one that provides the most balanced solutions, favoring to a lesser extent the areas with the highest epidemiological risk, which may be useful in the later stages of vaccination.

Indexed as

COVID-19Fair allocationOptimal distributionVaccines

Identifiers

PMID37255586
PMCPMC10011041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.